UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022600
Receipt number R000026050
Scientific Title The study of tissue regeneration and promotion of heeling for meniscal tear and regenerative meniscus.
Date of disclosure of the study information 2016/07/01
Last modified on 2021/06/08 16:10:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study of tissue regeneration and
promotion of heeling for meniscal
tear and regenerative meniscus.

Acronym

The study of tissue regeneration and
promotion of heeling for meniscal
tear and regenerative meniscus.

Scientific Title

The study of tissue regeneration and
promotion of heeling for meniscal
tear and regenerative meniscus.

Scientific Title:Acronym

The study of tissue regeneration and
promotion of heeling for meniscal
tear and regenerative meniscus.

Region

Japan


Condition

Condition

meniscal tear
degenerative meniscus

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose is to improve symptoms
by promoting blood flow by physical
stimulation to the meniscus

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The presence or absence of improvement in symptoms with a focus on IKDC scor

Key secondary outcomes

The presence or absence of improvement in MRI


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Control

Interventions/Control_2

Interventions
Extracorporeal shock wave irradiation group
Start the irradiation at 0.01mj / mm2 with no anesthesia using DUOLITH SD1(STORTS Medical CO,. Ltd.) Gradually energy while irradiating the 500 shots continue up until 0.25mj / mm2, it is irradiated with 2000 shots. This is enforced three times every other week.

Interventions/Control_3

Interventions
Ultrasound irradiation group
3 weeks irradiation every day for 20 minutes of ultrasound using SAFHS 4000J(TEIJIN Pharma CO,. Ltd.)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1 Over 20 year old patient diagnosed with meniscal tear in MRI.

2 Osteoarthritis of knee patient diagnosed Kellgren-Laurence classification 1-2 with meniscal degeneration in MRI.

Key exclusion criteria

1 cases with underlying disease such as rheumatoid arthritis, traumatic knee osteoarthritis, psedogout.
2 cases treated with anti-inflammatory analgesic and opioid, Neurotropin within 2 weeks prior to start of this study.
3 cases treated with steroid oral and intra-articular injection within 4 weeks prior to start of this study.
4 cases participated in other clinical study within the start of this study before 16 weeks.
5 cases with heart disease, liver dysfunction, kidney dysfunction, mental illness to be a clinical problem.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masataka Deie

Organization

Aichi Medical University

Division name

Department of Orthopaedic Surgery

Zip code


Address

1-1 Karimata, Yazako, Nagakute-shi, Aichi, Japan

TEL

0561-62-3311

Email

snm@aichi-med-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Machiko Akao

Organization

Aichi Medical University

Division name

Department of Orthopaedic Surgery

Zip code


Address

1-1 Karimata, Yazako, Nagakute-shi, Aichi, Japan

TEL

0561-62-3311

Homepage URL


Email

akao@aichi-med-u.ac.jp


Sponsor or person

Institute

Aichi Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛知医科大学病院 Aichi Medical University Hospital


Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 05 Month 13 Day

Date of IRB

2016 Year 05 Month 13 Day

Anticipated trial start date

2016 Year 07 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 06 Month 04 Day

Last modified on

2021 Year 06 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026050


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name